maprotiline has been researched along with Exanthem in 1 studies
Maprotiline: A bridged-ring tetracyclic antidepressant that is both mechanistically and functionally similar to the tricyclic antidepressants, including side effects associated with its use.
Excerpt | Relevance | Reference |
---|---|---|
" The first 2 days patients received a high initial dosage of 300 mg per day." | 2.64 | [Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)]. ( Angst, J; Gmuer, M; Hess, K; Hurwitz, E; Martens, H; Rothweiler, R; Steiner, A; Woggon, B, 1976) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Woggon, B | 1 |
Angst, J | 1 |
Gmuer, M | 1 |
Hess, K | 1 |
Hurwitz, E | 1 |
Martens, H | 1 |
Rothweiler, R | 1 |
Steiner, A | 1 |
1 trial available for maprotiline and Exanthem
Article | Year |
---|---|
[Clinical double-blind study with two different dosages of maprotiline (150 and 225 mg per day) (author's transl)].
Topics: Adult; Anthracenes; Clinical Trials as Topic; Depression; Dose-Response Relationship, Drug; Exanthem | 1976 |